Brigimadlin (BI 907828) is an orally active and highly potent E3 ubiquitin-protein ligase MDM2-p53 antagonist with antitumor activity.Brigimadlin can be used to study metastatic BTC, PDAC, lung adenocarcinoma, or bladder cancer.
Molecular Weight:
591.46
Purity:
98.17%
CAS Number:
[2095116-40-6]
Formula:
C31H25Cl2FN4O3
Target:
Mdm2|||E1/E2/E3 Enzyme|||MDM-2/p53|||p53
T69923
* VAT and and shipping costs not included. Errors and price changes excepted